Literature DB >> 26802780

Severity of Cortical Thinning Correlates With Schizophrenia Spectrum Symptoms.

Rebecca E Watsky1, Katharine Ludovici Pollard1, Deanna Greenstein1, Lorie Shora1, Diane Dillard-Broadnax1, Peter Gochman1, Liv S Clasen1, Rebecca A Berman1, Judith L Rapoport1, Nitin Gogtay1, Anna E Ordóñez1.   

Abstract

OBJECTIVE: This study investigated the relationship between regional cortical gray matter thinning and symptoms of schizophrenia spectrum personality disorders (PDs) in siblings of patients with childhood-onset schizophrenia (COS).
METHOD: A total of 66 siblings of patients with COS were assessed for symptoms of schizophrenia spectrum PDs (avoidant, paranoid, schizoid, schizotypal). Structural magnetic resonance images were obtained at approximately 2-year intervals from the siblings and from 62 healthy volunteers matched for age, sex, ethnicity, and handedness. Cortical thickness measures were extracted. Mixed effect regression models were used to test the relationship between symptoms and cortical gray matter thickness in siblings. Cortical thinning was also tested longitudinally in healthy volunteers and siblings.
RESULTS: Cortical thinning was found to correlate with symptoms of schizotypal and, to a lesser extent, schizoid PDs. Thinning was most pronounced in the left temporal and parietal lobes and right frontal and parietal regions. Gray matter loss was found to be continuous with that measured in COS. Longitudinal thinning trajectories were found not to differ between siblings and healthy volunteers.
CONCLUSION: The present investigation of cortical thinning in siblings of patients with COS indicates that symptoms of schizophrenia spectrum PDs correlate with regional gray matter loss. This finding supports the idea of cortical thinning as a schizophrenia endophenotype. Published by Elsevier Inc.

Entities:  

Keywords:  childhood-onset schizophrenia; cortical thinning; psychosis; schizophrenia spectrum; schizotypal personality disorder

Mesh:

Year:  2015        PMID: 26802780      PMCID: PMC4724380          DOI: 10.1016/j.jaac.2015.11.008

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  36 in total

1.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data.

Authors:  J G Sled; A P Zijdenbos; A C Evans
Journal:  IEEE Trans Med Imaging       Date:  1998-02       Impact factor: 10.048

2.  Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset schizophrenia.

Authors:  R G Ross; A Olincy; J G Harris; A Radant; M Hawkins; L E Adler; R Freedman
Journal:  Am J Med Genet       Date:  1999-04-16

Review 3.  Annotation: childhood-onset schizophrenia.

Authors:  J R Asarnow
Journal:  J Child Psychol Psychiatry       Date:  1994-11       Impact factor: 8.982

4.  Quantitative magnetic resonance imaging of human brain development: ages 4-18.

Authors:  J N Giedd; J W Snell; N Lange; J C Rajapakse; B J Casey; P L Kozuch; A C Vaituzis; Y C Vauss; S D Hamburger; D Kaysen; J L Rapoport
Journal:  Cereb Cortex       Date:  1996 Jul-Aug       Impact factor: 5.357

5.  Antibodies to heat shock proteins in schizophrenic patients: implications for the mechanism of the disease.

Authors:  M J Schwarz; M Riedel; R Gruber; M Ackenheil; N Müller
Journal:  Am J Psychiatry       Date:  1999-07       Impact factor: 18.112

6.  Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia.

Authors:  Rob Nicolson; Frances B Brookner; Marge Lenane; Peter Gochman; Loring J Ingraham; Michael F Egan; Kenneth S Kendler; David Pickar; Daniel R Weinberger; Judith L Rapoport
Journal:  Am J Psychiatry       Date:  2003-03       Impact factor: 18.112

7.  Childhood-onset schizophrenia: an NIMH study in progress.

Authors:  C T Gordon; J A Frazier; K McKenna; J Giedd; A Zametkin; T Zahn; D Hommer; W Hong; D Kaysen; K E Albus
Journal:  Schizophr Bull       Date:  1994       Impact factor: 9.306

8.  Schizotypal symptoms and signs in the Roscommon Family Study. Their factor structure and familial relationship with psychotic and affective disorders.

Authors:  K S Kendler; M McGuire; A M Gruenberg; D Walsh
Journal:  Arch Gen Psychiatry       Date:  1995-04

9.  The assessment of schizotypal features over two points in time.

Authors:  E Squires-Wheeler; A E Skodol; L Erlenmeyer-Kimling
Journal:  Schizophr Res       Date:  1991-12       Impact factor: 4.939

Review 10.  The pathophysiology of schizophrenia disorders: perspectives from the spectrum.

Authors:  Larry J Siever; Kenneth L Davis
Journal:  Am J Psychiatry       Date:  2004-03       Impact factor: 18.112

View more
  5 in total

1.  Developmental Trajectories of Cortical Thickness in Relation to Schizotypy During Adolescence.

Authors:  Mélodie Derome; Emiliana Tonini; Daniela Zöller; Marie Schaer; Stephan Eliez; Martin Debbané
Journal:  Schizophr Bull       Date:  2020-03-05       Impact factor: 9.306

2.  Associating Psychotic Symptoms with Altered Brain Anatomy in Psychotic Disorders Using Multidimensional Item Response Theory Models.

Authors:  Ana D Stan; Carol A Tamminga; Kihwan Han; Jong Bae Kim; Jaya Padmanabhan; Neeraj Tandon; Matthew E Hudgens-Haney; Matcheri S Keshavan; Brett A Clementz; Godfrey D Pearlson; John A Sweeney; Robert D Gibbons
Journal:  Cereb Cortex       Date:  2020-05-14       Impact factor: 5.357

3.  Cognitive Empathy and Longitudinal Changes in Temporo-Parietal Junction Thickness in Schizophrenia.

Authors:  Tatiana Karpouzian-Rogers; Derin Cobia; Julie Petersen; Lei Wang; Vijay A Mittal; John G Csernansky; Matthew J Smith
Journal:  Front Psychiatry       Date:  2021-05-14       Impact factor: 4.157

4.  Cognitive Functioning and Schizotypy: A Four-Years Study.

Authors:  Penny Karamaouna; Chrysoula Zouraraki; Stella G Giakoumaki
Journal:  Front Psychiatry       Date:  2021-01-08       Impact factor: 4.157

5.  Widespread Cortical Thickness Is Associated With Neuroactive Steroid Levels.

Authors:  Rajendra A Morey; Sarah L Davis; Courtney C Haswell; Jennifer C Naylor; Jason D Kilts; Steven T Szabo; Larry J Shampine; Gillian J Parke; Delin Sun; Chelsea A Swanson; Henry R Wagner; Christine E Marx
Journal:  Front Neurosci       Date:  2019-11-12       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.